Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Seattle Genetics, Inc. today presented interim results from a phase I clinical trial evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (PDA) at the American Society of Clinical Oncology (ASCO) 2013 Gastrointestinal Cancers Symposium being held January 24-26, 2013 in San Francisco, CA.

28 Jan 2013

Novartis receives FDA approval for Ph+ acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).

27 Jan 2013

New evidence supports thrombolysis in presence of contraindications

A Norwegian study offers further evidence to support the use of intravenous thrombolysis to treat stroke even in patients with contraindications to the drug.

25 Jan 2013

US physicians show conservative approach to end-of-life sedation

Intentionally sedating patients to unconsciousness until death is neither widely practiced nor supported by US physicians, a national survey indicates.

25 Jan 2013

Tailored treatments and PSA screenings required to improve health outcomes in Ghana

Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country's most threatening epidemic: cancer.

25 Jan 2013

High blood calcium levels may predict ovarian cancer

A new study from Wake Forest Baptist Medical Center is the first to report that high blood calcium levels might predict of ovarian cancer, the most fatal of the gynecologic cancers.

25 Jan 2013

RaySearch Laboratories receives order for RayStation treatment planning from Spain

RaySearch Laboratories AB has received an order for its RayStation® treatment planning from Consorcio Hospitalario Provincial de Castellón in Castellón, Spain.

25 Jan 2013

Dr. Reddy's Laboratories introduces Desloratadine ODT in the US market

Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.

25 Jan 2013

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

New research into the treatment and prognosis of gastrointestinal cancers was released today in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA.

24 Jan 2013

Researchers discover unique hairpin-like structure that facilitates Abeta clumping

Alzheimer's disease is the most common cause of late-life dementia. The disorder is thought to be caused by a protein known as the amyloid-beta protein, or Abeta, which clumps together in the brain, forming plaques that are thought to destroy neurons. This destruction starts early, too, and can presage clinical signs of the disease by up to 20 years.

24 Jan 2013

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they entered into an Asset Purchase Agreement (APA) whereby Baxter International (Baxter) agrees to acquire the worldwide rights to OBI-1, a recombinant porcine factor VIII (rpFVIII) in development for congenital hemophilia A with inhibitors and acquired hemophilia A, and Ipsen's industrial facility in Milford (Boston, MA).

24 Jan 2013

Study examines associations between blood calcium and ovarian cancer

A new study from Wake Forest Baptist Medical Center is the first to report that high blood calcium levels might predict ovarian cancer, the most fatal of the gynecologic cancers.

24 Jan 2013

KLF6-SV1 gene variant drives the spread of breast cancer

A team of researchers led by Goutham Narla, MD, PhD, at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, and collaborators at the Mount Sinai School of Medicine and Erasmus Medical Center, have discovered a gene variant that drives the spread of breast cancer.

23 Jan 2013

Scientists identify consistent epigenetic signatures in men with metastatic prostate cancer

In a genome-wide analysis of 13 metastatic prostate cancers, scientists at the Johns Hopkins Kimmel Cancer Center found consistent epigenetic "signatures" across all metastatic tumors in each patient.

23 Jan 2013

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).

23 Jan 2013

Novartis receives FDA approval for Exjade to treat chronic iron overload in NTDT patients

The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).

23 Jan 2013

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

23 Jan 2013

Actavis seeks FDA approval to market generic Opana ER

Watson Pharmaceuticals, Inc. today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Oxymorphone Hydrochloride Extended-release Tablets.

23 Jan 2013

Interventional Radiology launches IR Quarterly magazine

Interventional Radiology announces the launch of IR Quarterly-a new magazine that communicates updates critical to the practice of interventional radiology, augmented with stories, interviews and in-depth analysis in each four-color, 40-page issue. IR Quarterly delivers quality reporting on political advocacy, practice management and the latest specialty news and information.

23 Jan 2013

GeneDiagnostics, WILEX partner to commercialize serum HER-2/neu ELISA test in China

WILEX AG today announced that its US subsidiary WILEX Inc., Cambridge, MA, has entered into an exclusive distribution agreement with GeneDiagnostics Inc. for the commercialization of the serum HER-2/neu ELISA test in China.

23 Jan 2013

Oncology News and Research

Further Reading

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Novartis receives FDA approval for Ph+ acute lymphoblastic leukemia

New evidence supports thrombolysis in presence of contraindications

US physicians show conservative approach to end-of-life sedation

Tailored treatments and PSA screenings required to improve health outcomes in Ghana

High blood calcium levels may predict ovarian cancer

RaySearch Laboratories receives order for RayStation treatment planning from Spain

Dr. Reddy's Laboratories introduces Desloratadine ODT in the US market

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

Researchers discover unique hairpin-like structure that facilitates Abeta clumping

Inspiration, Ipsen and Baxter enter Asset Purchase Agreement for OBI-1

Study examines associations between blood calcium and ovarian cancer

KLF6-SV1 gene variant drives the spread of breast cancer

Scientists identify consistent epigenetic signatures in men with metastatic prostate cancer

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Novartis receives FDA approval for Exjade to treat chronic iron overload in NTDT patients

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Actavis seeks FDA approval to market generic Opana ER

Interventional Radiology launches IR Quarterly magazine

GeneDiagnostics, WILEX partner to commercialize serum HER-2/neu ELISA test in China

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News